Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo.
暂无分享,去创建一个
[1] K. Aldape,et al. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. , 2015, Neuro-oncology.
[2] J. D. de Groot,et al. Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects , 2014, Clinical Cancer Research.
[3] P. Kondaiah,et al. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. , 2014, Journal of neurosurgery.
[4] S. Ryu,et al. Proteomic analysis of hypoxia‐induced U373MG glioma secretome reveals novel hypoxia‐dependent migration factors , 2014, Proteomics.
[5] J. Y. Kim,et al. HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines , 2014, Genes & cancer.
[6] R. Baxter,et al. IGF binding proteins in cancer: mechanistic and clinical insights , 2014, Nature Reviews Cancer.
[7] F. Wenz,et al. The influence of retinoic Acid and thalidomide on the radiosensitivity of u343 glioblastoma cells. , 2014, Anticancer research.
[8] R. Wu,et al. Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma , 2014, Genes & cancer.
[9] T. Cloughesy,et al. Glioblastoma: from molecular pathology to targeted treatment. , 2014, Annual review of pathology.
[10] F. Wenz,et al. Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line , 2013, Journal of Neuro-Oncology.
[11] R. Baxter,et al. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells , 2013, Molecular and Cellular Endocrinology.
[12] Y. Kodera,et al. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma , 2013, Molecular Cancer.
[13] Pengcheng Zhu,et al. Emerging Roles of Angiopoietin-like 4 in Human Cancer , 2012, Molecular Cancer Research.
[14] P. Dollé,et al. Retinoic acid signalling during development , 2012, Development.
[15] J. L. Ding,et al. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. , 2011, Cancer cell.
[16] K. Thennarasu,et al. Grade-Specific Expression of Insulin-like Growth Factor–Binding Proteins-2, -3, and -5 in Astrocytomas: IGFBP-3 Emerges as a Strong Predictor of Survival in Patients with Newly Diagnosed Glioblastoma , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[17] B. Montanini,et al. Eukaryotic snoRNAs: a paradigm for gene expression flexibility. , 2009, Genomics.
[18] G. Duester. Retinoic Acid Synthesis and Signaling during Early Organogenesis , 2008, Cell.
[19] E. Domany,et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] F. Lohr,et al. Inhibition of 13-cis retinoic acid-induced gene expression of homeobox B7 by thalidomide , 2007 .
[21] C. Chomienne,et al. Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells , 2007, Oncogene.
[22] R. Myers,et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.
[23] M. Blagosklonny. How avastin potentiates chemotherapeutic drugs: Action and reaction in antiangiogenic therapy , 2005, Cancer biology & therapy.
[24] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] Yusuke Nakamura,et al. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. , 2005, Cancer research.
[26] Erwin G. Van Meir,et al. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.
[27] Susan M. Chang,et al. A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. , 2005, International journal of radiation oncology, biology, physics.
[28] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[29] Susan M. Chang,et al. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. , 2004, International journal of radiation oncology, biology, physics.
[30] K. Hess,et al. 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. , 2004, Neuro-oncology.
[31] Erwin G. Van Meir,et al. Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis , 1997, The Journal of experimental medicine.
[32] Kuender D Yang,et al. Induction of Interleukin-8 Expression in Neuroblastoma Cells by Retinoic Acid: Implication of Leukocyte Chemotaxis and Activation , 1993, Pediatric Research.
[33] E. Dmitrovsky,et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.
[34] W. Yung,et al. Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. , 1989, Cancer research.
[35] S. D. de Armond,et al. Effect of retinoids on the proliferation, morphology and expression of glial fibrillary acidic protein of an anaplastic astrocytoma cell line , 1988, International journal of cancer.
[36] N. Sidell,et al. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. , 1982, Journal of the National Cancer Institute.
[37] Peter Vaupel,et al. Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications. , 2014, Advances in experimental medicine and biology.
[38] N. Banik,et al. Molecular Mechanisms of the Combination of Retinoid and Interferon-gamma for Inducing Differentiation and Increasing Apoptosis in Human Glioblastoma T98G and U87MG Cells , 2008, Neurochemical Research.
[39] A. Koong,et al. Epigenetic Regulation of Gene Expression in Cervical Cancer Cells by the Tumor Microenvironment 1 , 2000 .